95 related articles for article (PubMed ID: 31099000)
1. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
Su YL; Swiderski P; Marcucci G; Kortylewski M
Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
[TBL] [Abstract][Full Text] [Related]
2. Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
Capolla S; Argenziano M; Bozzer S; D'Agaro T; Bittolo T; De Leo L; Not T; Busato D; Dal Bo M; Toffoli G; Cavalli R; Gattei V; Bomben R; Macor P
Front Immunol; 2023; 14():1200310. PubMed ID: 37359561
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different chemically modified inhibitors of miR-199b in vivo.
Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional oligodeoxynucleotide/antagomiR constructs: evaluation of a new tool for microRNA silencing.
Ziegler S; Eberle ME; Wölfle SJ; Heeg K; Bekeredjian-Ding I
Nucleic Acid Ther; 2013 Dec; 23(6):427-34. PubMed ID: 24236889
[TBL] [Abstract][Full Text] [Related]
5. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
Connelly CM; Deiters A
Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.
Plank MW; Maltby S; Tay HL; Stewart J; Eyers F; Hansbro PM; Foster PS
PLoS One; 2015; 10(12):e0144810. PubMed ID: 26693910
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion.
Bijkerk R; Esguerra JLS; Ellenbroek JH; Au YW; Hanegraaf MAJ; de Koning EJ; Eliasson L; van Zonneveld AJ
Nucleic Acid Ther; 2019 Apr; 29(2):67-72. PubMed ID: 30672723
[TBL] [Abstract][Full Text] [Related]
9. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
[TBL] [Abstract][Full Text] [Related]
10. Direct uptake of Antagomirs and efficient knockdown of miRNA in primary B and T lymphocytes.
Haftmann C; Riedel R; Porstner M; Wittmann J; Chang HD; Radbruch A; Mashreghi MF
J Immunol Methods; 2015 Nov; 426():128-33. PubMed ID: 26187895
[TBL] [Abstract][Full Text] [Related]
11. Assessing Anti-miR Pharmacology with miRNA Polysome Shift Assay.
Androsavich JR
Methods Mol Biol; 2017; 1517():103-113. PubMed ID: 27924477
[TBL] [Abstract][Full Text] [Related]
12. An Antagomir to MicroRNA-106b-5p Ameliorates Cerebral Ischemia and Reperfusion Injury in Rats Via Inhibiting Apoptosis and Oxidative Stress.
Li P; Shen M; Gao F; Wu J; Zhang J; Teng F; Zhang C
Mol Neurobiol; 2017 May; 54(4):2901-2921. PubMed ID: 27023223
[TBL] [Abstract][Full Text] [Related]
13. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles.
Kwekkeboom RF; Sluijter JP; van Middelaar BJ; Metz CH; Brans MA; Kamp O; Paulus WJ; Musters RJ
J Control Release; 2016 Jan; 222():18-31. PubMed ID: 26616760
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MicroRNA-21 by an antagomir ameliorates allergic inflammation in a mouse model of asthma.
Lee HY; Lee HY; Choi JY; Hur J; Kim IK; Kim YK; Kang JY; Lee SY
Exp Lung Res; 2017 Apr; 43(3):109-119. PubMed ID: 28379062
[TBL] [Abstract][Full Text] [Related]
16. Specificity, duplex degradation and subcellular localization of antagomirs.
Krützfeldt J; Kuwajima S; Braich R; Rajeev KG; Pena J; Tuschl T; Manoharan M; Stoffel M
Nucleic Acids Res; 2007; 35(9):2885-92. PubMed ID: 17439965
[TBL] [Abstract][Full Text] [Related]
17. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus.
Jimenez-Mateos EM; Engel T; Merino-Serrais P; Fernaud-Espinosa I; Rodriguez-Alvarez N; Reynolds J; Reschke CR; Conroy RM; McKiernan RC; deFelipe J; Henshall DC
Brain Struct Funct; 2015 Jul; 220(4):2387-99. PubMed ID: 24874920
[TBL] [Abstract][Full Text] [Related]
18. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal control of microRNA function using light-activated antagomirs.
Connelly CM; Uprety R; Hemphill J; Deiters A
Mol Biosyst; 2012 Nov; 8(11):2987-93. PubMed ID: 22945263
[TBL] [Abstract][Full Text] [Related]
20. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
Gambari R; Brognara E; Spandidos DA; Fabbri E
Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
